Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
Institute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste, Italy.
Front Endocrinol (Lausanne). 2024 Sep 3;15:1456541. doi: 10.3389/fendo.2024.1456541. eCollection 2024.
Brain magnetic resonance imaging (MRI) is mandatory or highly recommended in many pediatric endocrinological conditions to detect causative anatomic anomalies and rule out neoplastic lesions. However, MRI can also show findings associated with the underlying clinical condition, as well as unrelated "incidentalomas". These latter findings are often abnormalities with a high incidence in the general population for which there is no clear literature regarding their management, especially in pediatric patients. The present study aimed to evaluate the number of unnecessary performed MRIs in pediatric endocrinology.
Retrospective analysis on 584 MRI scans performed in 414 patients (254 growth hormone deficiency, 41 other causes of short stature, 116 central precocious puberty).
The MRI scans were completely normal in 67% of the individuals, and the prevalence of individuals who underwent more than one MRI was 18%, with no significant differences among the groups. The overall prevalence of incidentalomas was 17%. Among 170 repeated MRI scans, 147 (86%) were not required according to a dedicated protocol. Only five patients (four GHD, one Noonan) correctly repeated the MRI. All the repeated MRI scans did not reveal any progression in the findings. If we include the MRIs performed in cases of OCSS other than Noonan syndrome (n=32) and girls with CPP older than 6 years (n=89), an additional 121 MRIs could have been avoided, leading to a total number of unnecessary MRIs to 268 (46%).
Only a few specific neuroimaging findings in endocrinologic pediatric patients warrant further investigation, while too often repeated imaging is carried out unnecessarily. We advocate the importance of guidelines to reduce costs for both the healthcare system and patients' families, as well as to alleviate physical and psychological distress for patients and caregivers.
在许多儿科内分泌疾病中,脑磁共振成像(MRI)是必需的或强烈推荐的,以检测致病的解剖异常并排除肿瘤性病变。然而,MRI 也可以显示与潜在临床情况相关的发现,以及与潜在临床情况无关的“偶发瘤”。这些后者的发现通常是在一般人群中发病率较高的异常情况,对于这些异常情况,目前尚无明确的文献报道其处理方法,尤其是在儿科患者中。本研究旨在评估儿科内分泌中不必要的 MRI 数量。
对 414 例患者(254 例生长激素缺乏症、41 例其他身材矮小原因、116 例中枢性性早熟)的 584 例 MRI 扫描进行回顾性分析。
67%的个体 MRI 扫描完全正常,有 18%的个体进行了多次 MRI 检查,各组间无显著差异。偶发瘤的总患病率为 17%。在 170 次重复 MRI 扫描中,根据专门的协议,有 147 次(86%)不需要重复扫描。只有 5 名患者(4 名 GHD,1 名 Noonan)正确重复了 MRI。所有重复的 MRI 扫描均未显示发现任何进展。如果我们将 Noonan 综合征以外的 OCSS(n=32)和年龄大于 6 岁的 CPP 女孩(n=89)的 MRI 检查包括在内,则可以避免另外 121 次 MRI 检查,从而使不必要的 MRI 总数达到 268 次(46%)。
只有少数特定的内分泌儿科患者的神经影像学发现需要进一步研究,而太多时候会进行不必要的重复成像。我们提倡制定指南的重要性,以降低医疗保健系统和患者家庭的成本,并减轻患者和护理人员的身体和心理困扰。